B01D2313/40

Molecular separations process

A molecular separation method can include: passing a deasphalted oil stream through a reactor containing an active substrate, wherein the catalytic active substrate adsorbs heteroatom species from the deasphalted oil stream and produces a pretreated hydrocarbon feed stream essentially free of 4+ ring aromatic molecules (ARC 4+ species), metal species, and heteroatom species; and chromatographically separating with a simulated moving bed apparatus or a true moving bed apparatus (SMB/TMB) the pretreated hydrocarbon feed stream into a saturate fraction and an aromatics fraction.

Gasless extra-corporeal carbon dioxide removal

A carbon dioxide absorption medium. The absorption medium includes a plurality of hollow fibers and a plurality of binder particles. The hollow fibers have walls comprising a selectively permeable membrane that is configured to permit passage of gaseous carbon dioxide but not liquids. The plurality bind particles are dispersed between the hollow fibers and comprise an absorbent material configured to absorb gaseous carbon dioxide and to bind the carbon dioxide in a solid state.

Portable device and system for generating sterile water and method for the same

A system for generating sterile water is provided, including: a liquid holding container having thereon a container outlet; a filtration device including therein a low-pressure-differential pathogen filtration portion, wherein the filtration device has a filtration inlet and a filtration outlet; and a gas tube; wherein the container outlet is connected to the filtration inlet; wherein the filtration inlet has a gas hole with one end connected to the gas hole and the other end having a buoy; wherein the sterile water is substantially pathogen-free.

DIALYSATE FREE ARTIFICIAL KIDNEY DEVICE

A device and method are described for the treatment of blood, which device may be used in conjunction with or in place of a failed Kidney. The device includes an ultrafiltration unit to remove proteins, red and white blood cells and other high molecular weight components, a nanofiltration unit to remove glucose, at least one electrodeionization unit to transport ions from the blood stream, and a reverse osmosis unit to modulate the flow of water, to both the blood and urine streams. In one embodiment, a specialized electrodeionization unit is provided having multiple chambers defining multiple dilute fluid channels, each channel filled with an ion specific resin wafer, and electrodes at the extremity of the device and proximate each of the resin filled dilute channels. By selective application of voltages to these electrodes, the ion transport functionality of a given dilute channel can be turned on or off.

TREATMENT METHOD OF FLUID TO BE TREATED BY ZEOLITE MEMBRANE
20210245113 · 2021-08-12 ·

Provided is a method of efficiently treating a fluid to be treated containing a compound that destroys a zeolite membrane to prevent the fluid from destroying the zeolite membrane. A fluid to be treated 10 formed of a liquid mixture or a gas mixture and containing a compound that destroys a zeolite membrane 2 is brought into contact with particles (3, 5) made of the same type of zeolites as the zeolite membrane 2 and filling a pretreatment device 4 installed upstream of a membrane module 1 including the zeolite membrane 2 or a portion upstream of the zeolite membrane 2 in the membrane module 1 to destroy the zeolite forming the particles (3, 5) and the fluid to be treated 10 is made to contain a component generated by the destruction.

LATERAL FILTER ARRAY MICROFLUIDIC DEVICE
20210236992 · 2021-08-05 ·

A lateral filter array microfluidic (LFAM) device for highly efficient immunoaffinity isolation of target cells from a population of cells. The LFAM device may include of one or more serpentine main channels incorporated with lateral filter arrays. Antibodies are immobilized on the channel surface including the lateral filters and are capable of specific binding to one or more biomolecules on the surface of the target cell. The device may include one or more arrays of lateral filters with different sizes. The overall filters sizes are close to the diameter of the target cell, therefore the interaction between biomarkers on the target cells and corresponding antibodies immobilized on the filter surface is largely strengthened due to the direct contact between target cells and lateral filters. Methods include flowing a population of cells through an antibody-coated LFAM device for target cells capture, followed by washing the device to remove non-specific captured cells.

Treatment method of fluid to be treated by zeolite membrane
11090618 · 2021-08-17 · ·

Provided is a method of efficiently treating a fluid to be treated containing a compound that destroys a zeolite membrane to prevent the fluid from destroying the zeolite membrane. A fluid to be treated 10 formed of a liquid mixture or a gas mixture and containing a compound that destroys a zeolite membrane 2 is brought into contact with particles (3, 5) made of the same type of zeolites as the zeolite membrane 2 and filling a pretreatment device 4 installed upstream of a membrane module 1 including the zeolite membrane 2 or a portion upstream of the zeolite membrane 2 in the membrane module 1 to destroy the zeolite forming the particles (3, 5) and the fluid to be treated 10 is made to contain a component generated by the destruction.

CERAMIC CATION EXCHANGE MATERIALS

Cation exchange membranes and materials including silica-based ceramics, and associated methods, are provided. In some aspects, cation exchange membranes that include a silica-based ceramic that forms a coating on and/or within a porous support membrane are described. The cation exchange membranes and materials may have certain structural or chemical attributes (e.g., pore size/distribution, chemical functionalization) that, alone or in combination, can result in advantageous performance characteristics in any of a variety of applications for which selective transport of positively charged ions through membranes/materials is desired. In some embodiments, the silica-based ceramic contains relatively small pores (e.g., substantially spherical nanopores) that may contribute to some such advantageous properties. In some embodiments, the cation exchange membrane or material includes sulfonate and/or sulfonic acid groups covalently bound to the silica-based ceramic.

COMPOSITE HOLLOW FIBER MEMBRANE, MANUFACTURING METHOD THEREFOR, HOLLOW FIBER MEMBRANE CARTRIDGE INCLUDING SAME, AND FUEL CELL MEMBRANE HUMIDIFIER
20210154624 · 2021-05-27 ·

The present invention relates to a composite hollow fiber membrane, a manufacturing method therefor, a hollow fiber membrane cartridge including same, and a fuel cell membrane humidifier, the composite hollow fiber membrane comprising a hollow fiber membrane and a contaminant collection layer coated on the inner surface of the hollow fiber membrane. The composite hollow fiber membrane can prevent performance deterioration of a fuel cell by removing, without a separate gas filtering device, contaminants such as nitrogen oxide (NO.sub.x), sulfur oxide (SO.sub.x), and ammonia (NH.sub.3) during a humidifying process.

Affinity chromatography devices

The present invention is directed to affinity chromatography devices that separate a targeted protein or antibody from an aqueous mixture containing the targeted protein or antibody. The chromatography device may contain a stacked membrane assembly or a wound membrane assembly. The membrane assemblies include at least one polymer membrane that contains therein inorganic particles. The polymer membrane and/or the inorganic particles have an affinity ligand bonded thereto. The affinity ligand may be a protein, an antibody, or a polysaccharide that reversibly binds to the targeted protein or antibody. The chromatography device may be repeatedly used and may be cleaned with a caustic solution between uses. The chromatography devices may have a dynamic binding capacity (DBC) of at least 30 mg/ml (or 0.07 micromol/ml) at 10% breakthrough at a residence time of 20 seconds or less.